BMJ Connections Oncology (BMJCO)

BMJ Connections Oncology is a broad scope, international, open access, and peer reviewed journal from BMJ dedicated to the oncologic specialties. BMJ Connections Oncology aims to be a leading international platform for the dissemination of peer-reviewed research in the field of oncology. The journal seeks to bridge the gap between clinical practice, scientific research, and translational applications, fostering an integrated approach to understanding and treating cancer. BMJ Connections Oncology welcomes submissions in the following areas: Clinical Research: Studies focusing on the diagnosis, treatment, and management of cancer in patients. This includes clinical trials, cohort studies, and observational studies that provide insights into patient outcomes, treatment efficacy, and safety. Scientific Research: Basic and applied research that enhances our understanding of cancer biology, genetics, and the molecular mechanisms underlying cancer development and progression. This includes studies on cellular and molecular pathways, biomarkers, and novel therapeutic targets. Translational Research: Research that bridges the gap between laboratory findings and clinical application. This includes preclinical studies, development of new diagnostic tools, and translational studies that move discoveries from bench to bedside. Review Articles: Comprehensive reviews that summarize current knowledge and advancements in specific areas of oncology. These articles provide context and insight into complex topics and emerging trends. Practice and Policy: Articles that address the practical aspects of oncology care, including guidelines, best practices, policy changes, and the impact of healthcare systems on cancer treatment and outcomes.

BMJ Connections Oncology (BMJCO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Clinical Research, Cancer Biology, Translational Research, Cancer Genetics, Molecular Mechanisms of Cancer, Health Policy in Oncology , Online , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 3049-5784, Established: 2024,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE